Publisher: Elsevier

Related content
Volume 4, Number 2, 1 February 1999

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Nitric oxide: from basic research to clinical applications
pp. 47-49(3)
Authors: Green, I.C.; Chabrier, P.

Favourites:Add to Favourites

Strategies and technologies in functional genomics
pp. 50-53(4)
Author: Jain, K.K.

Favourites:Add to Favourites

Paralysis prevention drug
pp. 53-53(1)
Author: Bradley, D.

Favourites:Add to Favourites
Favourites:Add to Favourites

Proteomics: a major new technology for the drug discovery process
pp. 55-62(8)
Authors: Page, M.J.; Amess, B.; Rohlff, C.; Stubberfield, C.; Parekh, R.

Favourites:Add to Favourites

Selective proteasome inhibitors: modulators of antigen presentation?
pp. 63-71(9)
Authors: Groettrup, M.; Schmidtke, G.

Favourites:Add to Favourites

How antibiotics cause antibiotic resistance
pp. 72-79(8)
Author: Heinemann, J.A.

Favourites:Add to Favourites

Opportunities for novel therapeutic agents acting at chemokine receptors
pp. 80-92(13)
Authors: Saunders, J.; Tarby, C.M.

Favourites:Add to Favourites

Monitor: molecules and profiles
pp. 93-94(2)
Author: Lloyd, A.W.

Favourites:Add to Favourites

Combinatorial chemistry
pp. 95-96(2)
Author: Terrett, N.

Favourites:Add to Favourites

Molecular cancer target: PI-3-kinase
pp. 96-96(1)
Author: Gurwitz, D.

Favourites:Add to Favourites

Immunomodulatory antivirals
pp. 97-98(2)
Author: Zdek, Z.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more